567 related articles for article (PubMed ID: 9417296)
1. [Heredity in renal and prostatic neoplasia].
Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
3. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
4. Precancerous lesions in the kidney.
Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
[TBL] [Abstract][Full Text] [Related]
5. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
6. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel VHL targets that are associated with the development of renal cell carcinoma.
Abdulrahman M; Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Wiesener MS; Richards FM; Johnson CM; Latif F; Maher ER
Oncogene; 2007 Mar; 26(11):1661-72. PubMed ID: 17001320
[TBL] [Abstract][Full Text] [Related]
9. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
Shuin T; Kamata M; Ashida S
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1719-25. PubMed ID: 12402420
[TBL] [Abstract][Full Text] [Related]
10. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
[TBL] [Abstract][Full Text] [Related]
11. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.
Seizinger BR; Smith DI; Filling-Katz MR; Neumann H; Green JS; Choyke PL; Anderson KM; Freiman RN; Klauck SM; Whaley J
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2864-8. PubMed ID: 2011596
[TBL] [Abstract][Full Text] [Related]
12. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
13. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
[TBL] [Abstract][Full Text] [Related]
14. Familial renal cell carcinoma from the Swedish Family-Cancer Database.
Liu H; Sundquist J; Hemminki K
Eur Urol; 2011 Nov; 60(5):987-93. PubMed ID: 21621909
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
16. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of renal carcinogenesis.
Walker C
Toxicol Pathol; 1998; 26(1):113-20. PubMed ID: 9502393
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
19. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
[TBL] [Abstract][Full Text] [Related]
20. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]